| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Verve Therapeutics, Inc. | Chief Administrative Officer | Restricted Stock Units | 0 | $74,700 | $4.15 | 25 Jul 2025 | Direct |
| Verve Therapeutics, Inc. | Chief Administrative Officer | Common Stock | 0 | $0 | $11.23 | 25 Jul 2025 | Direct |
| Verve Therapeutics, Inc. | Chief Administrative Officer | Restricted Stock Unuits | 6,630 | 01 Apr 2025 | Direct | ||
| Verve Therapeutics, Inc. | Chief Administrative Officer | Stock Option (right to buy) | 0 | 25 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VERV | Verve Therapeutics, Inc. | 25 Jul 2025 | 7 | $0 | 4 | Chief Administrative Officer | 28 Jul 2025, 17:15 |
| VERV | Verve Therapeutics, Inc. | 01 Apr 2025 | 4 | -$11,525 | 4 | Chief Administrative Officer | 03 Apr 2025, 17:00 |
| VERV | Verve Therapeutics, Inc. | 08 Jan 2025 | 2 | $0 | 4 | Chief Administrative Officer | 10 Jan 2025, 09:00 |
| VERV | Verve Therapeutics, Inc. | 01 Apr 2024 | 3 | -$12,475 | 4 | Chief Administrative Officer | 03 Apr 2024, 17:00 |
| VERV | Verve Therapeutics, Inc. | 14 Feb 2024 | 2 | $0 | 4 | Chief Administrative Officer | 16 Feb 2024, 16:30 |
| VERV | Verve Therapeutics, Inc. | 15 Feb 2023 | 0 | $0 | 3 | Chief Administrative Officer | 23 Feb 2023, 16:00 |